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Abstract
Background Intraoperatively fabricated polymethylmethacrylate
(PMMA) implants based on computer-designed moulds
were used to improve cosmetic results after hard tissue
replacement. To assess the implant’s cosmetic and func-
tional results we performed both subjective and objective
assessments.
Methods This retrospective analysis was performed using a
cohort of 28 patients who received PMMA implants between
February 2009 and March 2012. The cosmetic and functional
results were assessed using a patient questionnaire. Further-
more an objective volumetric subtraction score (0–100) was
applied and implant thickness, as well as gaps and tiers, were
measured.
Results Patients mainly judged their cosmetic result as
“good”. Two of the 28 patients found their cosmetic result
unfavourable. The functional result and stability was mainly
judged to be good. Measurements of implant thickness
showed a very high correlation with the thickness of the
contralateral bone. Volumetric subtraction led to a median
quality of 80 on a scale from 0 to 100. Median gaps around
the margins of the implant were 1.5 mm parietally, 1.7 mm
frontally and 3.5 mm fronto-orbitally, and median tiers were
1.2 mm, 0 mm and 0 mm respectively. The overall rate of
surgical revisions was 10.7 % (three patients). Two patients
suffered from wound healing disturbances (7.1 %). The over-
all complication rate was comparable to other reports in the
literature.
Conclusions Implantation of intraoperatively fabricated
patient-specific moulded implants is a cost-effective and safe
technique leading to good clinical results with a low compli-
cation rate.
Keywords hemicraniectomy . PMMA . PSI . PSMI . Skull
reconstruction
Introduction
Advances in neurosurgery and intensive care over the last 2
decades have achieved great improvement in the outcomes of
patients with severe head trauma, stroke, brain tumours and
infectious diseases affecting the skull. Surgical treatment often
involves a large osteoclastic craniotomy or delayed reimplan-
tation of the autologous bone flap. In many of these cases a
reconstruction of the skull is necessary because of (1) destruc-
tion of the bone as result of trauma, (2) infection, (3) tumour
infiltration, or (4) aseptic necrosis and resorption of the bone
flap [20].
There are several techniques and materials available for
preservation of the explanted bone-flap and its replacement [2,
5, 8, 13, 14, 17–19]. These techniques differ in functionality,
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cosmetic result, costs and spectrum of complications involved
in the procedures. Among the artificial materials,
polymethylmethacrylate (PMMA) is the least expensive and
most commonly used [2, 18]. The material is usually applied
directly to the patient and moulded to the skull defect using
free-hand cranioplasty, which often results in a suboptimal
cosmetic result (Fig. 1).
Better cosmetic and very good functional results can be
achieved using preoperatively designed patient specific im-
plants (PSIs) that have a low complication rate [5, 19]. Dif-
ferent materials have been used for this purpose, all with good
results. The most commonly used are titanium and polyether-
ether-ketone (PEEK) [13]. To achieve optimal cosmetic and
functional results at a similar cost as the PMMA implants we
developed a technique of intraoperativemoulding of a PMMA
implant on a patient-specific mould [12]. To evaluate the
functional and cosmetic outcome of these patients, we per-
formed a retrospective analysis of a consecutive series of 28
patients.
Methods and materials
Patients
Between February 2009 and March 2012 we performed 28
plastic reconstructions of the skull using the patient-specific
moulded implant (PSMI) technique. Of these patients, 11 were
female and 17 male. Indications for cranial reconstruction
using artificial material were: resorption of the reimplanted
autologous bone flap in 12 patients (42.8 %), infection of the
autologous bone so it could not be reimplanted in nine patients
(32.1 %), infiltration by tumour in three patients (10.7 %), loss
of the autologous bone following inter-hospital transfer in
three patients (10.7 %), and relevant resorption followed by
instability of the reimplanted autologous bone flap in one
patient (3.6 %). One case was a bifrontal defect involving
the brow, one a combined bifrontal and lateral decompression,
24 were hemicraniectomies involving one half of the forehead
and the temporal region; only in two cases were visible parts
of the face affected.
Creation of mould template
The mould template was created using high-resolution com-
puted tomography (CT) scans of each patient. Two different
techniques were used for making the mould: Subtraction of
post-explantation CT from a pre-explantation CT, if available,
or subtraction from the mirrored contralateral side. If available
scans were of adequate quality (at least 2.5-mm slice thick-
ness), no new scans were acquired to reduce costs and the
patients’ radiation doses. In most of the cases an emergency
CT scan of adequate quality (1.27 mm slice thickness), which
was acquired before hemicraniectomy, was available and
served as pre-explantation CT.
There were two variants for creation of the mould, referred
to as Variant A and Variant B.
Variant A The CT scans were loaded into the BrainLab iPlan
neuronavigation software (Version 3.0; BrainLab,
Feldkirchen, Germany). After image fusion of the
available scans a three-dimensional (3D) volume
rendering was performed using Hounsfield
thresholding (200>I[x, y, z]>3,071). Partially re-
sorbed bone, drainages and other objects were
manually erased from the object until a perfect
3D model of the skull and the bony defect was
created.
Using the same procedure a second 3D model
of the intact skull was created using the pre-
explantation CT. Then the second model was dig-
itally subtracted from the first, resulting in a 3D
model of the intended PSMI. The model of the
intact skull was digitally filled out and the model
of the PSMI was subtracted. This resulted in a
digital version of the mould for creation of the
Palacos-PSMI (Fig. 2). To reduce material needed
for 3D printing, non-required parts such as the
contralateral side were removed, leading to a
mould that showed about one1 cm of the surface
of the surrounding bone.
Variant B If no pre-explantation CT was available, the 3D
model of the skull with the bony defect was
Fig. 1 Postoperative CT scan of a free-hand PMMA cranioplasty—a
ideal shape of the cranioplasty; b the achieved shape of the cranioplasty is
too flat
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mirrored and manually adjusted to meet the shape
of the opposite side using iPlan. Then the
resulting mirrored object was shrunk by 3–4 mm
(the intended thickness of the resulting PSMI) and
fused to the non-mirrored 3Dmodel, resulting in a
mould for PSMI creation. The mould was then
isolated from the intact parts of the skull, which
are irrelevant for the creation of the PSMI, using
the split-tool of iPlan.
The resulting object was exported as an STL
file (“Surface Tesselation Language” 3D file for-
mat) and transferred to a 3D printer (Spectrum
Z™ 510 printer; Z-Corporation, Rock Hill, SC,
USA), a high-speed printing device allowing the
production of pieces up to 300×200×300 mm
with a resulting printing resolution of 0.1 mm. It
uses standard inkjet printing technology to create
parts layer-by-layer by depositing a liquid binder
onto thin layers of powder. After completion of
the printing process and drying of the binder
solution, excessive powder material around the
template model was removed and the mould was
infiltrated with polyurethane.
Intraoperative workflow
The mould was brought into the sterile area of the operating
room (OR) in an airtight sterile plastic bag, in which plastic
tubing was previously inserted and connected to a vacuum
suction device (Fig. 3A). After activation of the suction, the
plastic bag neatly covered the surface of the mould (Fig 3B).
The PSMI was then formed from polymethylmethacrylate
bone cement (PMMA) on the sterile surface of the mould
(Fig. 3C). After hardening of the PSMI a series of holes was
drilled into it to allow exchange of fluid or blood between the
Fig. 2 Creation of mould
template. Step 1: The post-
explantation CT is subtracted
from the pre-explantation CT. The
result is a 3D model of the
required PSMI (flap). Step 2: The
3D model of the flap is subtracted
from the pre-explantation CT,
which is then digitally “filled
out”. After elimination of non-
required parts such as the
contralateral side and zygoma the
result is a 3D model of the mould
Fig. 3 Intraoperative creation of
patient-specific moulded implant
(PSMI). AThemould was brought
into the OR in an air-tight sterile
plastic bag (a), which was
connected with the vacuum
suction using a flexible tube (b). B
After removal of the air inside the
plastic bag using the vacuum
suction the plastic neatly covered
the mould surface. C The PSMI
was created from PMMA on the
mould’s surface. DAfter
hardening of the PMMA, holes
were drilled into the PSMI. EThe
implant was placed into the defect
and was fixed using low-profile
titanium plates and screws
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epidural and the subgaleal space and to facilitate fixation of
the dura at the implant through tissue growth into the holes
(Fig. 3D). The PSMI was then fixed into the bony defect using
titanium plates and screws (Fig. 3E). To prevent subgaleal and
epidural haematoma, a subgaleal drainage was implanted in
all cases.
Time investment in the procedure
The whole procedure, from planning of the 3D mould until
implantation, could be performed within 24 h if necessary,
which was done in one case. Creating the digital 3D mould
using BrainLab iPlan took, depending on the quality of the CT
images, size and location of the bone defect, between 1 and 2 h
in the hands of an experienced person. Rapid prototyping of
the mould took approximately 2.4 h for a volume of 350 cm3.
The binder solution required drying overnight and infiltration
with polyurethane. The process of creating a PSMI implant
using the mould took approximately 30 min altogether.
Postoperative neuroimaging
Postoperative CT was performed in case of clinical necessity
(e.g. headache onset) to rule out complications such as epidu-
ral haematomas or hygromas requiring revision. In cases with
perfect clinical and cosmetic results, we dispensed with post-
operative imaging to reduce unnecessary application of radi-
ation to the patients.
Patients’ subjective assessments of implant quality
To judge the cosmetic results of the PSMI implantations, all
patients were asked to answer a catalogue of questions
concerning their subjective estimation of their status at least
3 months postoperatively. Seventeen patients (61 %) filled in
the questionnaire. One patient could not be contacted postop-
eratively as he moved to an unknown address. The questions
were the following: general satisfaction with the result of the
surgery, satisfaction with the cosmetic result, peculiarity of
scars, satisfaction with skull shape, symmetry, and palpable
Fig. 4 Volumetric bone flap
subtraction examples. AThe 3D
reconstruction of the bone after
implantation of a PSMI (in white)
is subtracted from the 3D model
of the ideal bone flap. The
resulting volume (yellow) is
representative for the “quality” of
the PSMI shape. In this example
the PSMI is a little too flat in the
frontal region, which results in a
considerable volume after
subtraction (a). B In this example
the PSMI is not in the perfect
position, resulting in a small
subtraction volume on the inside
(b). C In the third example the
PSMI is quite well shaped, but
very thin compared with the
contralateral side. This results in
an interior (c) and exterior (d)
volume after subtraction. The
dura shows signs of calcification
(e). D In the last example the
shape and position of the PSMI
are perfect. The outer surface of
the implant is optimal. The
thickness does not correspond
with the contralateral side
everywhere, but is absolutely
sufficient
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gaps or tiers around the implant (each indicated with an
ordinal six-step scale from very poor to excellent). Finally,
the patients were asked to judge their general condition pre-
operatively and postoperatively (six-step scales from very
poor to excellent). Statistical significance was tested using
two-sample Wilcoxon test. P values less than 0.05 were con-
sidered significant.
Objective assessments of implant quality—Volumetric bone
flap subtraction
The available postoperative CT scans for 19 patients (68 %)
were closely examined and parameters were measured to
judge the objective quality and fit of the implant. Avolumetric
reconstruction of the implanted PSMI and surrounding skull
(Hounsfield units 200–3,071) was subtracted from the 3D
model of the ideal flap (result of step 1 in Fig. 2). In case of
a perfectly sized, shaped and implanted PSMI, this should
lead to a complete extinction of the ideal flap model, with a
volume of 0 cm3. The other extreme, in which there was no
overlap of the two structures, would be the full volume of the
flap model. The resulting volume was set in relation to the
volume of the ideal flap model to achieve a result independent
from the size of the implanted PSMI (Fig. 4). The result is
subtracted from 1 and multiplied by 100 to generate a “quality
grade” ranging from 0 (no overlapping between PSMI and
ideal flapmodel) to 100 (perfect size, shape and implantation).
Gaps between bone and PSMI implant were measured in
axial planes at three spots: Postero-superior (parietal), antero-
superior (frontal) and antero-inferior (fronto-orbital), in
millimetres. There were no measurements in the temporal
region, as the implants were mostly not designed to cover
the inferior portion of the temporal decompression. In addition
to gaps, the thickness of tiers was measured in millimetres.
The thickness of the PSMI was measured in millimetres via
axial CT in the centre of the implant and on the corresponding
contralateral side.
Objective assessments of implant quality—Calculation
of the dice similarity coefficient
A standardised procedure to measure identity of two volumet-
ric objects is calculation of the dice similarity coefficient
(DSC) [21] according to the following formula:
DSC ¼ 2 A∩Bð Þ= Aþ Bð Þ
DSC Dice similarity coefficient
A Volume (cm2) of the ideal flap model
B Volume (cm2) of the implanted PSMI
Values range between 0 (no overlapping of two objects)
and 1 (perfect match).
Table 1 Complications after PSMI implantation
n Patient IDs
Infection of unknown origin 0
Infection after wound healing disturbance 2 (7.1 %) 4, 25
Haematoma 2 (7.1 %) 5, 23
Hygroma 2 (7.1 %) 13, 16
Subcutaneous CSF leak (transient) 1 (3.6 %) 24
Subcutaneous CSF leak (persistent) 2 (7.4 %) 1
Hydrocephalus 1 (3.7 %) 13
Incidence of complications after implantation of a PSMI. The patient IDs
correspond to the cases in Table 2
Fig. 5 Cosmetic outcome after PSMI implantation. Patients were asked postoperatively to judge the cosmetic results on ordinal 6-step scales from very
poor to excellent. The numbers represent the cases in Table 2
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Results
Surgical outcome and complications
All patients recovered well from surgery. One case of postop-
erative epidural haematoma required surgical revision. One
patient with delayed epidural haematomawas readmitted from
rehabilitation because of new hemiparesis and deterioration of
vigilance; she was successfully treated by trepanation and
evacuation of a chronic haematoma at the centre of the PSMI
and implantation of an epidural drain for 48 h. In one patient, a
subcutaneous cerebrospinal fluid (CSF) collection was allevi-
ated after transdermal puncture and evacuation. In another
patient, the CSF collection slowly regressed without treat-
ment. In one further patient, conservative treatment of a sub-
cutaneous CSF collection was not successful and the patient
recovered well after implantation of a VP shunt on the con-
tralateral side. Two patients experienced wound-healing dis-
turbances with opening of the scar over the titanium plates.
Both showed no signs of local or systemic infection. In both
patients the PSMI was removed and a new one was created
using the same mould 4 weeks later. One of them recovered
well, but the other suffered repeated wound healing distur-
bances and required repeated revision of the implant and
closure of the skin using free tissue transplants (Table 1).
Cosmetic results
In general, the patients judged the surgical results as good
(Fig. 5). Both patients with wound healing disturbances found
their result ‘good’. Two of the patients with postoperative
subcutaneous CSF collections found their result even ‘excel-
lent’. Most patients found their cosmetic result acceptable and
scars, skull shape and symmetry of the head ‘good’. Figure 6
shows 3D reconstructions of case 25, who judged skull shape,
symmetry and gaps and tiers to be ‘very poor’. However, to
the observer the result does not look bad.
Other clinical results
There was a significant improvement in the general condition
in our cohort of PSMI patients (p=0.024, Fig. 7). The one
patient who reported that his general condition deteriorated
postoperatively, from excellent to very poor, is the same
patient who judged his cosmetic results as poor (Fig. 6).
Objective assessment of PSMI quality in postoperative CT
scan—Volumetric bone flap subtraction
The median volume of the ideal flap was 98.3 cm3 (SD 34.9).
After subtraction of the volumetric reconstruction of the im-
planted PSMI and surrounding bone the median overlapping
volume was 22.3 cm3 (SD 18.5). The median calculated
objective quality grade was 80 (SD 18.0, Table 2).
Gaps and tiers were smallest in the postero-superior
(parietal) region, where an average gap of 2.2 mm (SD 2.1)
Fig. 6 Illustrative 3D views of case 25. The 3D reconstructions show the
fit of the PSMI of case 25 (seeTable 2), who judged gaps and tiers “very
poor”. ALateral view; B frontal view; C posterior view—a titanium low-
profile microfixation plates, b small gap cranial of the petrous bone, cgap
from dehiscent lamdoid suture resulting from the initial trauma; d recon-
struction artefact (scan did not cover the most posterior parts of the skull)
Fig. 7 Patients’ general conditions before and after PSMI implantation.
Patients were asked preoperatively and postoperatively to judge their
condition on ordinal six-step scales from very poor to excellent. The
numbers represent the cases in Table 2. Only one patient (11) encountered
a relevant subjective deterioration
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and a median of 1.5 mm were measured. Tiers were mainly
inward (average 0.9 mm, SD 0.9, median 1.2 mm). In the
antero-superior (frontal) location the average gap was 3.5 mm
(SD 5.7, median 1.7 mm) and the tier was 0.2 mm outward
(SD 1.1, median 0 mm). In the antero-inferior (fronto-orbital)
location the average gap was 3.8 mm (SD 2.7, median
3.5 mm) and the average inward tier 0.1 mm (SD 1.0, median
0.0 mm, Table 2).
The thickness of the PSMIs corresponded well with the
thickness of the contralateral bone. The average PSMI thick-
ness was 4.0 mm (SD 0.8, median 3.8 mm, range 3.2–6 mm).
On the contralateral, side the average bone thickness was
4.2 mm (SD 0.9, median 4.0 mm, range 2.7–6.1 mm). The
average difference between PSMI and contralateral bone
thickness was −0.2 mm (SD 0.9, median 0.0 mm, range
−2.9 to 1.3 mm, Table 2).
Discussion
Improvements in intensive care as well as neuroimaging and
microsurgical techniques have led to a growing number of
indications for hard tissue replacement (HTR) in cranial neu-
rosurgery. There are numerous materials available for this
purpose, all of which have their individual advantages. The
most commonly used and cheapest is polymethylmethacrylate
Table 2 Objective judgement of PSMI quality
No. Volumetric assessment Thickness at centre
Missing bone volume
(“ideal flap”) (cm3)
Overlap
(cm3)
Quality grade
(0–100)
DSC (0–1) PSMI (mm) Contra-lateral bone
(mm)
Relation (%)
1 80.6 6.7 92 0.72 3.5 3.5 100
2 53.3 18.9 65 0.66 3.2 3.2 100
3 88.7 41.9 53 0.6 3.5 3.7 95
4 No postop CT available
5 67.9 18.2 73 0.69 6.0 4.7 128
6 No postop CT available
7 93.4 12.1 87 0.69 3.3 2.7 122
8 137.5 24.5 82 0.84 3.2 6.1 52
9–11 No postop CT available
12 99.7 49.9 50 0.54 3.7 3.7 100
13 125.1 24.8 80 0.71 3.9 4.1 95
14 No postop CT available
15 128.3 75.6 41 0.38 4.4 4.3 102
16 98.8 7.9 92 0.8 3.6 4.4 82
17 98.3 5.72 94 0.76 5.8 4.0 145
18 No postop CT available
19 130.0 18.1 86 0.63 3.5 3.9 90
20 46.3 1.1 98 0.77 4.3 4.8 90
21 No postop CT available
22 91.9 28.1 69 0.66 3.9 3.9 100
23 124.0 21.9 82 0.7 4.0 5.2 77
24 177.7 35.1 80 0.76 4.5 4.6 98
25 135.7 46.1 66 0.68 4.8 5.1 94
26 No postop CT available
27 88.7 42.6 52 0.52 5.1 3.5 146
28 40.9 22.3 45 0.47 4.1 4.2 98
Mean 100.3 26.4 73 0.66 4.1 4.2 101
Median 98.3 22.3 80 0.69 3.9 4.1 98
SD 34.9 18.5 18 0.12 0.8 0.8 22
The result was evaluated by volumetric subtraction of the PSMI from a 3D object representing the missing bone. The overlapping volumewas then put in
relation with the volume of the missing bone. The resulting quality grade ranges from 0 to 100. The median result of our cases was 80. The median dice
similarity coefficient (DSC) was 0.69. The thickness of the implanted PSMI was measured and put in relation with the contralateral bone. The median
thickness was 98 %
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(PMMA) bone cement. It can be formed intraoperatively to fill
the bone defect, and is biocompatible and very stable. A
disadvantage is that the manually formed bone replacements
often have a suboptimal shape, leading to an inferior cosmetic
result. An alternative is the use of autologous bone (split
grafts) [1], but this is only available for small defects. Other
artificial bone replacements can be made of hydroxylapatite
(HA) bone cement, which is usually formed on a matrix of
titaniummesh (onlay technique). HA has the benefit that bone
can grow into the margins of the bone replacement and im-
prove the stability of the implant over time. Disadvantages are
the high costs and the high infection rate in published studies
[3, 4, 6, 8, 11, 15, 16]. Patient-specific implants (PSIs) are
usually designed based on CT scans of the patients and are
provided by specialised companies. They can be made from
titanium, polyether-ether-ketone (PEEK), other polymers,
PMMA, HA or biocompatible glass ceramic. What they all
have in common is that they usually fit into the defect per-
fectly and lead to an optimal cosmetic result. Unfortunately,
the costs for all of them are relatively high and range from
US$ 3,500 to more than US$ 5,000 per piece, depending on
the dimensions of the implant and the material [2, 3, 9].
Titanium, PEEK and ceramics can be resterilised in case of
surgical revision. Titanium has the disadvantage that it con-
ducts cold temperature far better than bone, which can be
uncomfortable for patients (Table 3) [2].
Alternatives to commercial PSIs
The only artificial alternatives to commercially available PSIs
are hand-made bone replacements from PMMA or HA bone
cement. PMMA is particularly inexpensive (less than US$
500 per piece) and is therefore frequently used even for
replacement of large bone defects. To achieve better cosmetic
results using this material, several different attempts were
made. One very simple approach was to form the bone re-
placement directly on the explanted bone flap [10]. This
technique has the potential disadvantage that a possibly in-
fected bone flap must be brought into the OR and even into
direct contact with the PMMA, leading to a risk of infection.
Though increased infection was not shown in the small num-
ber of published cases using this technique, it remains a
possible serious threat for patients. Another idea is to combine
the advantages of computer-assisted design with the benefits
of intraoperatively formed PMMA implants. In addition to the
PMMAmaterial, the costs for this technique are relatively low
(Z-Corporation Spectrum T510 3D printer is offered for about
US$ 10,000 and material for printing is below US$ 100 per
mould). Two publications in the literature describe the use of
computer-designed moulds [5, 16]. We independently devel-
oped a comparable technique and this report describes the
largest consecutive series operated upon using this method.
Furthermore, we provide patients’ assessments of the
cosmetic results and evaluation of postoperative CT scans
for a majority of the patients.
Results of patient-specific moulded implants
Complications were comparable with those reported for other
techniques, including both commercial PSIs and non-
commercial implants [7]. Infections related to wound healing
over the titanium plates and the screws were easily treated. No
complications were directly attributed to the material used or
to the technique. Patients were mainly satisfied with the
cosmetic results. Few patients complained about asymmetry
of their skull and palpable gaps and tiers around the implant.
Atrophy of the temporal muscle and poor overall neurological
condition or depression might have contributed to this result,
but it remains possible that commercial PSIs lead to slightly
better cosmetic results. A standard for assessment of the
postoperative result does not currently exist, which makes it
impossible to compare the outcomes of the different tech-
niques that have been described in the literature. We per-
formed volumetric subtractions of the postoperative CT scans
from the ideal bone flap models, resulting in an objective
quality scale ranging from 0 to 100. While the median quality
measured by this method was 80, four patients had values of
more than 90, indicating nearly absolute identity of the im-
planted PSMI with what would be an “ideal” implant. Eight
patients had values below 70, usually indicating a too thin or
too flat PSMI. Of these, five patients completed the question-
naire. Only one of them (case 25) judged his cosmetic result as
unfavourable. The others found it good or, in one case (case
2), even excellent. Only two of the patients (cases 11 and 25)
showed clear dissatisfaction with the PSMI implant. In one of
them (case 25) the postoperative CTscan corresponded with a
relatively low objective rating. In the other case (case 11) we
unfortunately did not have a postoperative CT scan available
for evaluation. Calculations of the dice similarity coefficient
(DSC) corresponded well with the quality scale. Cases with
values above 0.7 showed optimal shape and fit of the implant.
Weaknesses of the present study are the low rate of returned
patient questionnaires and the fact that not all patients received
a postoperative CT scan. A prospective study comparing the
results of commercially available PSIs with the PSMI tech-
nique reported here and described previously by Lee et al. [16]
and Fathi et al. [10] is needed to identify advantages and
disadvantages of the techniques.
Conclusions
Implantation of intraoperatively fabricated patient-specific
moulded implants is a cost-effective and safe technique that
leads to good clinical results with a low complication rate.
Calculation of the DSC and the volumetric subtraction
802 Acta Neurochir (2014) 156:793–803
technique presented here were appropriate for judging implant
shape and fit.
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